138 related articles for article (PubMed ID: 9069682)
1. Pemoline in adult attention deficit hyperactivity disorder: predictors of nonresponse.
Heiligenstein E; Anders J
J Am Coll Health; 1997 Mar; 45(5):225-9. PubMed ID: 9069682
[TBL] [Abstract][Full Text] [Related]
2. Pemoline therapy in college students with attention deficit hyperactivity disorder: a retrospective study.
Heiligenstein E; Johnston HF; Nielsen JK
J Am Coll Health; 1996 Jul; 45(1):35-9. PubMed ID: 8708264
[TBL] [Abstract][Full Text] [Related]
3. An open trial of pemoline in drug-dependent delinquents with attention-deficit hyperactivity disorder.
Riggs PD; Thompson LL; Mikulich SK; Whitmore EA; Crowley TJ
J Am Acad Child Adolesc Psychiatry; 1996 Aug; 35(8):1018-24. PubMed ID: 8755798
[TBL] [Abstract][Full Text] [Related]
4. A rare case of dependence on pemoline.
Bonnet U; Davids E
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1340-1. PubMed ID: 16600453
[TBL] [Abstract][Full Text] [Related]
5. Pemoline in ADHD.
Winsberg B; Barbato M
J Am Acad Child Adolesc Psychiatry; 1997 Dec; 36(12):1649-50. PubMed ID: 9401321
[No Abstract] [Full Text] [Related]
6. Pemoline effects on children with ADHD: a time-response by dose-response analysis on classroom measures.
Pelham WE; Swanson JM; Furman MB; Schwindt H
J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1504-13. PubMed ID: 8543519
[TBL] [Abstract][Full Text] [Related]
7. Controlled trial of high doses of pemoline for adults with attention-deficit/hyperactivity disorder.
Wilens TE; Biederman J; Spencer TJ; Frazier J; Prince J; Bostic J; Rater M; Soriano J; Hatch M; Sienna M; Millstein RB; Abrantes A
J Clin Psychopharmacol; 1999 Jun; 19(3):257-64. PubMed ID: 10350032
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents.
Riggs PD; Hall SK; Mikulich-Gilbertson SK; Lohman M; Kayser A
J Am Acad Child Adolesc Psychiatry; 2004 Apr; 43(4):420-9. PubMed ID: 15187802
[TBL] [Abstract][Full Text] [Related]
9. Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications.
Varley CK; Vincent J; Varley P; Calderon R
Compr Psychiatry; 2001; 42(3):228-33. PubMed ID: 11349243
[TBL] [Abstract][Full Text] [Related]
10. Attention-deficit hyperactivity disorder.
Calis KA; Grothe DR; Elia J
Clin Pharm; 1990 Aug; 9(8):632-42. PubMed ID: 1974836
[TBL] [Abstract][Full Text] [Related]
11. Psychotic side effects of psychostimulants: a 5-year review.
Cherland E; Fitzpatrick R
Can J Psychiatry; 1999 Oct; 44(8):811-3. PubMed ID: 10566114
[TBL] [Abstract][Full Text] [Related]
12. Response to growth hormone in attention deficit hyperactivity disorder: effects of methylphenidate and pemoline therapy.
Rao JK; Julius JR; Breen TJ; Blethen SL
Pediatrics; 1998 Aug; 102(2 Pt 3):497-500. PubMed ID: 9685452
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
[TBL] [Abstract][Full Text] [Related]
14. Pemoline-associated hepatic failure: a critical analysis of the literature.
Shevell M; Schreiber R
Pediatr Neurol; 1997 Jan; 16(1):14-6. PubMed ID: 9044395
[TBL] [Abstract][Full Text] [Related]
15. Pemoline treatment of adolescents with attention deficit hyperactivity disorder: a short-term controlled trial.
Bostic JQ; Biederman J; Spencer TJ; Wilens TE; Prince JB; Monuteaux MC; Sienna M; Polisner DA; Hatch M
J Child Adolesc Psychopharmacol; 2000; 10(3):205-16. PubMed ID: 11052410
[TBL] [Abstract][Full Text] [Related]
16. Pemoline (Cylert): market withdrawal.
Hogan V
CMAJ; 2000 Jan; 162(1):106, 110. PubMed ID: 11216184
[No Abstract] [Full Text] [Related]
17. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder.
Marcus SC; Wan GJ; Kemner JE; Olfson M
Arch Pediatr Adolesc Med; 2005 Jun; 159(6):572-8. PubMed ID: 15939858
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
Faraone SV; Glatt SJ
J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of stimulants in adult ADHD.
Maidment ID
Ann Pharmacother; 2003 Dec; 37(12):1884-90. PubMed ID: 14632541
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
Biederman J; Swanson JM; Wigal SB; Kratochvil CJ; Boellner SW; Earl CQ; Jiang J; Greenhill L
Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]